Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the effects of PACAP-38 and its analog, acetyl-[Ala15, Ala20] PACAP-38-propylamide, on spatial memory, post-learning BDNF expression and oxidative stress in rat.
Ladjimi MH, Barbouche R, Ben Barka Z, Vaudry D, Lefranc B, Leprince J, Troadec JD, Ben Rhouma K, Sakly M, Tebourbi O, Save E. Ladjimi MH, et al. Among authors: vaudry d. Behav Brain Res. 2019 Feb 1;359:247-257. doi: 10.1016/j.bbr.2018.10.023. Epub 2018 Oct 19. Behav Brain Res. 2019. PMID: 30343054
Neurotrophic effects of PACAP in the cerebellar cortex.
Botia B, Basille M, Allais A, Raoult E, Falluel-Morel A, Galas L, Jolivel V, Wurtz O, Komuro H, Fournier A, Vaudry H, Burel D, Gonzalez BJ, Vaudry D. Botia B, et al. Among authors: vaudry d, vaudry h. Peptides. 2007 Sep;28(9):1746-52. doi: 10.1016/j.peptides.2007.04.013. Epub 2007 May 1. Peptides. 2007. PMID: 17544170 Review.
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.
Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L. Raoult E, et al. Among authors: vaudry d, vaudry h. J Neurochem. 2011 Dec;119(5):920-31. doi: 10.1111/j.1471-4159.2011.07486.x. Epub 2011 Oct 24. J Neurochem. 2011. PMID: 21919910 Free article.
Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model.
Lamine A, Létourneau M, Doan ND, Maucotel J, Couvineau A, Vaudry H, Chatenet D, Vaudry D, Fournier A. Lamine A, et al. Among authors: vaudry d, vaudry h. Neuropharmacology. 2016 Sep;108:440-50. doi: 10.1016/j.neuropharm.2015.05.014. Epub 2015 May 22. Neuropharmacology. 2016. PMID: 26006268
Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
Aubert N, Basille M, Falluel-Morel A, Vaudry D, Bucharles C, Jolivel V, Fisch C, De Jouffrey S, Le Bigot JF, Fournier A, Vaudry H, Gonzalez BJ. Aubert N, et al. Among authors: vaudry d, vaudry h. J Comp Neurol. 2007 Oct 1;504(4):427-39. doi: 10.1002/cne.21451. J Comp Neurol. 2007. PMID: 17663433
195 results